title: Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
authors.affiliation: Biochemicals Division, Yamasa Corporation, Chiba, Japan. hayakawa@yamasa.com
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hayakawa
authors.forename: Satoru
authors.initials: S
authors.lastname: Kohgo
authors.forename: Kenji
authors.initials: K
authors.lastname: Kitano
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Ashida
authors.forename: Eiichi
authors.initials: E
authors.lastname: Kodama
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Mitsuya
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ohrui
mesh_terms: D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009705:Nucleosides / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D013329:Structure-Activity Relationship
chemical_list: D019380:Anti-HIV Agents; D009705:Nucleosides